Skip to main content
SpringerLink
Log in

Antithrombotic therapy in heart failure

  • Original Article – e-learning
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Patients with congestive heart failure have a significant risk of stroke due to thromboembolism from the dilated left ventricle. Two relatively small trials suggest that oral anticoagulation with vitamin-K antagonists may reduce this risk when compared with placebo, aspirin or clopidogrel. However, more studies are eagerly awaited. So far, physicians seeing patients with heart failure should decide who needs antithrombotic prophylaxis on a case-by-case basis, especially since most heart failure patients have significant comorbidity precluding the use of oral anticoagulant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Loh E, St John Sutton M, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251–7.

    Article  PubMed  CAS  Google Scholar 

  2. Teo KK, Yusuf S, Pfeffer M, et al. Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet. 2002;360:1037–43.

    Article  PubMed  CAS  Google Scholar 

  3. Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004;10:101–12.

    Article  PubMed  CAS  Google Scholar 

  4. Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Heart Failure (WATCH) Trial. Circulation. 2009;119:1616–24.

    Article  PubMed  CAS  Google Scholar 

  5. Cleland JGF, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies in patients with heart failure. Am Heart J. 2004;148:157–64.

    Article  PubMed  CAS  Google Scholar 

  6. Masoudi FA, Wolfe P. Havranek, et al. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J Am Coll Cardiol. 2005;46:955–62.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG), Oosterpark 9, 1091 AC, Amsterdam, the Netherlands

    F. W. A. Verheugt

Authors
  1. F. W. A. Verheugt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. W. A. Verheugt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verheugt, F.W.A. Antithrombotic therapy in heart failure. Neth Heart J 20, 176–178 (2012). https://doi.org/10.1007/s12471-012-0250-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12471-012-0250-5

Keywords

Search

Navigation